Hunan Nucien Pharmaceutical Co (SHSE:688189) Beta: 1.5356 (As of Jun. 27, 2026)


SHSE:688189 Hunan Nucien Pharmaceutical Co Ltd SHSE:688189
53 GF Score
Price ¥5.92
GF Value ¥2.38
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Hunan Nucien Pharmaceutical Co Beta?

Hunan Nucien Pharmaceutical Co SHSE:688189 -2.47% 53 Beta is 1.5356 as of Jun. 27, 2026. GuruFocus rates SHSE:688189 with a GF Score™ of 53/100 and a GF Value™ of ¥2.38 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-27), Hunan Nucien Pharmaceutical Co's Beta is 1.5356.


Hunan Nucien Pharmaceutical Co  (SHSE:688189) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Hunan Nucien Pharmaceutical Co Beta Related Terms


Hunan Nucien Pharmaceutical Co Beta Historical Data

* Premium members only.

The historical data trend for Hunan Nucien Pharmaceutical Co's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hunan Nucien Pharmaceutical Co Beta Chart

Hunan Nucien Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 1.10 1.01 1.30

Hunan Nucien Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.86 0.42 1.00 1.30 1.42

SHSE:688189 vs ZTS: Beta Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Hunan Nucien Pharmaceutical Co's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hunan Nucien Pharmaceutical Co Beta vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hunan Nucien Pharmaceutical Co's Beta distribution charts can be found below:

* The bar in red indicates where Hunan Nucien Pharmaceutical Co's Beta falls into.


SHSE:688189
53GF Score
Hunan Nucien Pharmaceutical Co Ltd SHSE:688189
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hunan Nucien Pharmaceutical Co Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 1.5356 mean?
Hunan Nucien Pharmaceutical Co (SHSE:688189) has a Beta of 1.5356 as of Jun. 27, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Hunan Nucien Pharmaceutical Co and its competitors.
Is Hunan Nucien Pharmaceutical Co's Beta too high?
Hunan Nucien Pharmaceutical Co's current Beta is 1.5356. Overall, Hunan Nucien Pharmaceutical Co has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hunan Nucien Pharmaceutical Co's Beta compare to ZTS?
Hunan Nucien Pharmaceutical Co's Beta of 1.5356 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Drug Manufacturers company?
A good Beta depends on the Drug Manufacturers industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Hunan Nucien Pharmaceutical Co and its competitors. Hunan Nucien Pharmaceutical Co's current Beta is 1.5356. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hunan Nucien Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Hunan Nucien Pharmaceutical Co (SHSE:688189) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥2.38, compared to a current price of ¥5.92 — trading 148.7% above its estimated fair value. The current Beta is 1.5356. Hunan Nucien Pharmaceutical Co's overall GF Score™ is 53/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Hunan Nucien Pharmaceutical Co (SHSE:688189), the current Beta is 1.5356 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hunan Nucien Pharmaceutical Co (SHSE:688189) Overvalued in 2026?

Based on GuruFocus' analysis, Hunan Nucien Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥5.92 is trading 148.7% above its estimated GF Value™ of ¥2.38. GuruFocus considers Hunan Nucien Pharmaceutical Co to be Significantly Overvalued.

Key valuation signals for SHSE:688189:

  • Beta: 1.5356
  • GF Value™: ¥2.38 vs. price of ¥5.92 (148.7% above fair value)
  • GF Score™: 53/100 with 2 warning signs

No single metric tells the full story. See the SHSE:688189 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hunan Nucien Pharmaceutical Co Business Description

Address No. 1 Kangli Road, Liuyang Economic and Technological Development Zone, Hunan Province, Changsha, CHN, 510100
Hunan Nucien Pharmaceutical Co Ltd is a pharmaceutical company integrating drug research and development, production and sales. The company focuses on anti-infection, cardio-cerebral vascular, anti-tumor and other pharmaceutical fields. The company's business scope includes the manufacturing and sales of chemical pharmaceutical preparations, chemical pharmaceutical raw materials, biological drugs, chemical reagents, and auxiliaries.
53GF Score

Get the complete analysis for SHSE:688189

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥5.92
Price
¥2.38
GF Value